C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2004
10/14/2004	US20040204338 Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action
10/14/2004	US20040203157 Transfroming arabidopsis with expression vector coding genes associated with heat, freeze, salt and drought resistance; using ribonucleoproteins to control effivient gene transcription in plants; bioreactors
10/14/2004	US20040203156 Transgenic cell comprising sequences coding viral envelope protein for use as bioreactors in genetic engineering
10/14/2004	US20040203155 Methods for transfecting T cells
10/14/2004	US20040203153 Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made
10/14/2004	US20040203151 Using nutrient broth comprising lateral bud explant of long pepper to propagate medicinal compounds for treatment of respiratory system disorders; bioreactors
10/14/2004	US20040203150 Culturing pine species in nutrient broth comprising auxins, cytokinin, sugars and abscisic acid; tissue engineering; seed mimetics
10/14/2004	US20040203149 Composite materials comprising supported porous gels
10/14/2004	US20040203148 Tissue propagation/regeneration apparatus comprising hydrogels; tissue engineering and biological scaffolds
10/14/2004	US20040203147 Method and structure for growing living organic tissue
10/14/2004	US20040203146 Composite scaffolds and methods using same for generating complex tissue grafts
10/14/2004	US20040203144 Using calcium-activated chloride channels (CLCA) to identify modulators for treatment of bronchitis, asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD) and bronchiectasis
10/14/2004	US20040203143 Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
10/14/2004	US20040203142 Culturing cord embryonic stem cells for use in transplantation and repair of nerve damage, stokes, spinal injury, parkinson's and alzheimer's disorders
10/14/2004	US20040203135 Application of b-staged divinylsiloxane-bis-benzocyclobutene for the growth and cultivation of biological materials
10/14/2004	US20040203130 Subtilisin variants
10/14/2004	US20040203125 recombinant chimera produced using solid phase synthesis; for biosnesors/bioreactors, diagnostic and drugs
10/14/2004	US20040203118 Polynucleotides and polypeptides of the IFNalpha-14 gene
10/14/2004	US20040203116 IL-1 eta DNA and polypeptides
10/14/2004	US20040203111 UDP-N-acetylglucosamine: galactose-B1,3-N-acetylgalactosamine-a-R/ (GlcNAc to GalNAc) B1-6 N- acetylglucosaminyltransferase, C2GnT3
10/14/2004	US20040203105 for drug screening emzyme inhibitors using genetically engineered animal models; for anticancer agents
10/14/2004	US20040203104 for drug screening enzyme inhibitors; genetic engineering; comprising subjecting the sample to a polymerase chain reaction, a northern hybridization assay or an in situ hybridization assay
10/14/2004	US20040203099 Conjugate of a transport protein and a protein for modulation of notch signalling
10/14/2004	US20040203098 Compounds and methods for modulating activation of NF-kappaB
10/14/2004	US20040203097 Kinases and phosphatases
10/14/2004	US20040203096 performed in vitro; for treatment of type II glycogen storage disease in mammals, including humans; genetic engineering
10/14/2004	US20040203095 from porcine pancreas in pichia pastoris which is soluble and secreted into the culture medium, whereby expression at pH 3.0-4.0 substantially prevents activation of trypsinogen to beta -trypsin and autolysis of beta-trypsin by alpha -trypsin
10/14/2004	US20040203092 UDP-N-acetylglucosamine:galactose-beta1,3-N-acetylgalactosamine-alpha-R/ (GlcNAc to GalNAc) beta1-6 N-acetylglucosaminyltransferase, C2GnT3
10/14/2004	US20040203070 Method and means for detecting alcohol consumption
10/14/2004	US20040203025 kit comprising extension, strand displacement, and optionally a termination sequence and with the amplification optionally involving transcription; genetic engineering
10/14/2004	US20040203020 Self-replicating RNA molecule from hepatitis C virus
10/14/2004	US20040203014 Neurotransmisson-associated proteins
10/14/2004	US20040203001 Methods for identifying human cell lines useful for endogenous gene activation, isolated human cell lines identified thereby, and uses thereof
10/14/2004	US20040202999 for drug screening treatments for human immunodeficiency virus (HIV), cancer; gene therapy; long terminal repeat sequences; genetic engineering
10/14/2004	US20040202671 helminths obtained from preparatory animals raised in a specific human pathogen-free environment used to treat an excessive immune response including an aberrant/enhanced Th1 response, e.g., Crohn's disease and ulcerative colitis
10/14/2004	US20040202662 Humanised antibodies
10/14/2004	US20040202659 A polypeptide encoded by a nucleic acid that encodes a heavy chain, which is able to bind to GPIIb/IIIa, of a human antibody and comprising a CDR3 region; diagnosis, treatment or prevention of autoimmune thrombocytopenic purpura; modulating blood coagulation
10/14/2004	US20040202650 Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies
10/14/2004	US20040202647 T cell line specific for a nitrotyrosine-containing compound; antibody specific for a self-antigen comprising a tyrosine to nitrotyrosine conversion; prevention and treatment of autoimmune diseases, infectious diseases and cancer through the recognition of compounds containing nitrated tyrosine residues
10/14/2004	US20040202646 Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy
10/14/2004	DE10313291A1 Medium for engineering of vascularized tissue and blood vessels, useful for making tissue for reconstructive surgery, includes somatotropin to improve stability or formation of a capillary-like network
10/14/2004	DE10295684T9 Verfahren zum spezifischen Hemmen von Histon-Deacetylase-4 Method for the specific inhibition of histone deacetylase 4
10/14/2004	CA2752312A1 Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm
10/14/2004	CA2752247A1 Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm
10/14/2004	CA2752218A1 Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm
10/14/2004	CA2521141A1 Method for the enrichment of target cells by use of cbds
10/14/2004	CA2521105A1 Materials and methods for regulating process formation in cell culture
10/14/2004	CA2520861A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway
10/14/2004	CA2520530A1 Method of producing lens cell and lens cell obtained by the method
10/14/2004	CA2520460A1 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation
10/14/2004	CA2519989A1 Process for the staining of sperm
10/14/2004	CA2518882A1 Apparatus and methods for providing sex-sorted animal sperm
10/13/2004	EP1467212A1 Process for differential diagnosis of Alzheimer's denmentia and device therefor
10/13/2004	EP1466968A2 Method and apparatus for encapsulation of biologically-active substances
10/13/2004	EP1466633A1 Composite scaffolds seeded with mammalian cells
10/13/2004	EP1466017A2 Tissue rejection
10/13/2004	EP1466013A2 Thermus scotoductus nucleic acid polymerases
10/13/2004	EP1466003A1 Herbal composition for improving oral hygiene, and methods of using same
10/13/2004	EP1465999A2 Fusion proteins
10/13/2004	EP1465998A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
10/13/2004	EP1465997A2 Use of biomolecular targets in the treatment and visualization of tumors
10/13/2004	EP1465996A2 Raf/ras binding compounds
10/13/2004	EP1465992A2 Pluripotent stem cells derived without the use of embryos or fetal tissue
10/13/2004	EP1465988A2 Myo-inositol oxygenases
10/13/2004	EP1465986A1 Gfp-transfected clon pig, gt knock-out clon pig and methods for production thereof
10/13/2004	EP1465985A2 High level cytokine production with enhanced cell viability
10/13/2004	EP1465984A1 A suprabasal breast cell line with stem cell properties
10/13/2004	EP1465983A2 Endothelial stem cells, populations, methods of isolation and use thereof
10/13/2004	EP1465982A1 Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
10/13/2004	EP1465981A2 Methods and compositions for generating a genetically modified animal using lentiviral vectors
10/13/2004	EP1465979A1 Chamber with adjustable volume for cell culture and organ assist
10/13/2004	EP1465928A2 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies
10/13/2004	EP1465925A2 Antibodies that immunospecifically bind to trail receptors
10/13/2004	EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy
10/13/2004	EP1465919A2 Insect g protein-coupled receptor genes and uses thereof
10/13/2004	EP1465918A2 Peptides promoting cell adherence, growth and secretion
10/13/2004	EP1465916A2 Novel g proein-coupled receptor, gave7
10/13/2004	EP1465912A2 Novel chimeric tnf ligands
10/13/2004	EP1465908A2 Compositions and methods for hydroxylating epothilones
10/13/2004	EP1465906A1 Compositions and methods relating to endometrial specific genes and proteins
10/13/2004	EP1465905A2 Antisense modulation of myd88 expression
10/13/2004	EP1465660A2 Methods and compositions for modulating regulation of the cytotoxic lymphocyte response by macrophage migration inhibitory factor
10/13/2004	EP1465659A2 Use of a novel cell surface protease from group b streptococcus
10/13/2004	EP1465657A2 Method of enhancing immunogenicity by covalent linkage of antigens to proteins on the surface of dendritic cells
10/13/2004	EP1465578A2 Antisense modulation of vascular endothelial growth factor receptor-1 expression
10/13/2004	EP1465493A1 Cultured and encapsulated pancreatic stem cells
10/13/2004	EP1465489A2 Methods of expressing lim mineralization protein in non-osseous cells
10/13/2004	EP1465481A1 Knockout swine and methods for making the same
10/13/2004	EP1286682A4 Methods and compositions for inhibiting immunoglobulin-mediated--reperfusion injury
10/13/2004	EP1257584B1 Humanized antibodies that sequester amyloid beta peptide
10/13/2004	EP1230374A4 Modification of polysaccharide containing materials
10/13/2004	EP1154786B1 Compositions for altering mucus secretion
10/13/2004	EP1135512B1 Artificial matrix attachment region for increasing expression of genes introduced in plant cells
10/13/2004	EP1102858B1 Cell lines for the propagation of mutated herpes viruses
10/13/2004	EP1012291B1 Multiple site delivery of adenoviral vector for the induction of angiogenesis
10/13/2004	EP0987998B1 Tissue decellularization
10/13/2004	EP0937155B1 Resistance against nematodes and/or aphids
10/13/2004	EP0921821B1 2-methoxyestradiol-induced apoptosis in cancer cells
10/13/2004	EP0876402B1 Growth hormone secretagogue receptor family
10/13/2004	EP0817847B1 Il-17 receptor

1 ... 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 ... 1827